SEC 13F Intelligence

Consonance Capital Management LP / TNDM

Consonance Capital Management LP’s Tandem Diabetes Care Inc Position

Does Consonance Capital Management LP own Tandem Diabetes Care Inc (TNDM)? Not currently — the last reported position was 4.3K shares worth $254,000 in Q2 2022; the fund’s latest 13F (Q3 2022) no longer reports it.

Position Value
$254,000
Q2 2022
Shares
4.3K
% of Portfolio
+1.07%
Quarters Held
7
position exited

Position History TNDM

Reported value by quarter
Q3 ’19: $60MQ3 ’19Q4 ’19: $33MQ4 ’19Q2 ’21: $95MQ2 ’21Q3 ’21: $58MQ3 ’21Q4 ’21: $45MQ4 ’21Q1 ’22: $17MQ1 ’22Q2 ’22: $254,000Q2 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20224.3K$254,000+1.07%
Q1 2022147.3K$17M+29.07%
Q4 2021300.7K$45M+29.52%
Q3 2021487.3K$58M+31.84%
Q2 2021979.2K$95M+11.48%
Q4 2019551.0K$33M+2.00%
Q3 20191.02M$60M+5.97%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Consonance Capital Management LP’s full portfolio or all institutional holders of TNDM.